Sangamo Therapeutics
SGMO
#10549
Rank
NZ$55.95 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-80.56%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): NZ-$0.65

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.69. In 2025 the company made an earnings per share (EPS) of NZ-$0.80 an increase over its 2024 EPS that were of NZ-$0.93.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.65-19.06%
2025NZ-$0.80-13.73%
2024NZ-$0.93
2022NZ-$2.280.81%
2021NZ-$2.2633.33%
2020NZ-$1.706.9%
2019NZ-$1.5922.54%
2018NZ-$1.301.43%
2017NZ-$1.28-31.37%
2016NZ-$1.8675.86%
2015NZ-$1.0648.72%
2014NZ-$0.71-17.02%
2013NZ-$0.869.3%
2012NZ-$0.78-39.44%
2011NZ-$1.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.19-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.72-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.31-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$2.32 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.66 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$36.16-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA